Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD

中性粒细胞 Nox2 控制炎症中的单核细胞功能;

基本信息

  • 批准号:
    10228694
  • 负责人:
  • 金额:
    $ 62.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-18 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary / Abstract Chronic granulomatous disease (CGD) is a rare, but devastating, disease with known genetic abnormalities in the phagocyte (white blood cell) oxidase. In addition to immunodeficiency (the inability to fight certain bacteria and fungi), patients with this disease often have complex and poorly understood abnormalities in inflammatory processes manifest as colitis, poor wound healing, obstructing granuloma, and autoimmunity. Importantly, there is a lack of clearly applicable and effective treatments for many of these inflammatory consequences. Our studies in an animal model of human X-linked CGD clearly point to abnormal crosstalk during inflammatory processes between two different types of phagocytes, both with the mutated oxidase: neutrophils (or granulocytes) and mononuclear phagocytes. Specifically, we have shown that whereas CGD neutrophils were unable control the recruitment, maturation, inflammatory programming and disposal of the mononuclear phagocytes at sites of inflammation, the direct introduction of normal neutrophils was able to restore these activities and events in vivo. As such, signals from normal neutrophils orchestrate the activities of the mononuclear phagocytes at each step in the normal development and resolution of inflammation. It is hypothesized that identifying these signals provided by normal neutrophils could provide new therapeutic strategies. Using the murine model and adoptive transfers of neutrophils and their products as well as cell co- culture experiments (ex vivo), this proposal aims to define the mechanisms underlying the abnormal mononuclear phagocyte behavior in CGD and the precise processes lacking in CGD neutrophils that are overcome by the addition of normal neutrophils. Defining these is expected to lead to novel approaches to treatment of CGD and possibly other chronic inflammatory conditions. .
项目摘要/摘要 慢性肉芽肿性疾病(CGD)是一种罕见但毁灭性的疾病,具有已知的遗传异常。 吞噬细胞(白血球)氧化酶。除了免疫缺陷(无法对抗某些细菌 和真菌),这种疾病的患者通常有复杂的和鲜为人知的炎性异常 病变表现为结肠炎、伤口愈合不良、阻塞性肉芽肿和自身免疫。重要的是 对于许多这些炎症性后果,缺乏明确适用和有效的治疗方法。 我们在人类X连锁CGD动物模型上的研究清楚地指出了炎症过程中的异常串扰 两种不同类型的吞噬细胞之间的过程,都带有突变的氧化酶:中性粒细胞(或 粒细胞)和单核巨噬细胞。具体地说,我们已经证明,尽管CGD中性粒细胞 无法控制单个核细胞的募集、成熟、炎性编程和处置 在炎症部位的吞噬细胞,直接引入正常的中性粒细胞能够恢复这些 活体内的活动和事件。因此,来自正常中性粒细胞的信号协调 单核巨噬细胞在正常发育和消退炎症的每一步。它是 假设识别这些由正常中性粒细胞提供的信号可以提供新的治疗方法 战略。采用小鼠模型和中性粒细胞及其产物的过继转移以及细胞共培养 培养实验(体外),这一建议旨在定义异常的机制 CGD中的单核吞噬细胞行为以及CGD中性粒细胞缺乏的精确过程 通过添加正常的中性粒细胞来克服。对这些的定义有望带来新的方法来 治疗CGD和可能的其他慢性炎症情况。 。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DONNA L BRATTON其他文献

DONNA L BRATTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DONNA L BRATTON', 18)}}的其他基金

Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD
中性粒细胞 Nox2 控制炎症中的单核细胞功能;
  • 批准号:
    10456072
  • 财政年份:
    2018
  • 资助金额:
    $ 62.65万
  • 项目类别:
Reversal of Inflammatory Processes in CGD
CGD 中炎症过程的逆转
  • 批准号:
    9416907
  • 财政年份:
    2014
  • 资助金额:
    $ 62.65万
  • 项目类别:
Reversal of Inflammatory Processes in CGD
CGD 中炎症过程的逆转
  • 批准号:
    8803304
  • 财政年份:
    2014
  • 资助金额:
    $ 62.65万
  • 项目类别:
Reversal of Inflammatory Processes in CGD
CGD 中炎症过程的逆转
  • 批准号:
    8669607
  • 财政年份:
    2014
  • 资助金额:
    $ 62.65万
  • 项目类别:
Cell Cuture Core
细胞培养核心
  • 批准号:
    8053034
  • 财政年份:
    2011
  • 资助金额:
    $ 62.65万
  • 项目类别:
Lyso-PS and resolution of acute lung inflammation
Lyso-PS 和急性肺部炎症的解决
  • 批准号:
    8053030
  • 财政年份:
    2011
  • 资助金额:
    $ 62.65万
  • 项目类别:
Macrophage PPARg signaling, efferocytosis, and exaggerated inflammation in CGD
CGD 中的巨噬细胞 PPARg 信号传导、胞吞作用和过度炎症
  • 批准号:
    8299285
  • 财政年份:
    2011
  • 资助金额:
    $ 62.65万
  • 项目类别:
Cell Culture Core
细胞培养核心
  • 批准号:
    7142913
  • 财政年份:
    2005
  • 资助金额:
    $ 62.65万
  • 项目类别:
Phospholipid signaling from apoptotic cells
来自凋亡细胞的磷脂信号传导
  • 批准号:
    7142871
  • 财政年份:
    2005
  • 资助金额:
    $ 62.65万
  • 项目类别:
Defective PS Exposure in Neutrophil Apoptosis in CGD
CGD 中中性粒细胞凋亡中的 PS 暴露缺陷
  • 批准号:
    6991217
  • 财政年份:
    2003
  • 资助金额:
    $ 62.65万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.65万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了